Pilar de la Peña

Pilar de la Peña

Auto-generated profile, based on publicly available information

Pilar de la Peña

Department of Biochemistry and Molecular Biology, University of Oviedo, 33006 Oviedo, Spain

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 1987 in Science
Verified
Journal Article
Closed access
PDF file
JLJuan Carlos Lacal
Juan Carlos Lacal
PPPilar de la Peña
Pilar de la Peña
JMJorge Moscat
Jorge Moscat
PGPedro Garcia-Barreno
Pedro Garcia-Barreno
PAPaul S. Anderson
Paul S. Anderson
SAStuart A. Aaronson
Stuart A. Aaronson
The p21 products of ras proto-oncogenes are thought to be important components in pathways regulating normal cell proliferation and differentiation. These proteins acquire transforming properties as a result of activating lesions that convert ras genes to oncogenes in a wide array of malignancies. In Xenopus laevis oocytes, microinjection of transforming ras p21 is a potent inducer of maturation, whereas microinjection of a monoclonal antibody to ras p21 inhibits normal maturation induced by hormones. The phosphoinositide pathway is a ubiquitous system that appears to play a key role in diverse cellular functions. By use of the Xenopus oocyte system, it was possible to quantitate the effects of ras p21 microinjection on individual components of the phosphoinositide pathway. Within 20 minutes of microinjection, levels of phosphatidylinositol 4,5-bisphosphate, inositol 1-phosphate, and inositol bisphosphate increased 1.5- to 2-fold. The most striking effects were on diacylglycerol, which increased 5-fold under the same conditions. In contrast, the normal ras p21 protein induced no detectable alteration in any of the metabolites analyzed. The earliest effects of the transforming p21 on phosphoinositol turnover were observable within 2 minutes, implying a very rapid effect of ras p21 on the enzymes involved in phospholipid metabolism.

30 March 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
ÉLÉva Lörinczi
Éva Lörinczi
JGJuan Camilo Gómez-Posada
Juan Camilo Gómez-Posada
PPPilar de la Peña
Pilar de la Peña
ATAdam P. Tomczak
Adam P. Tomczak
JFJorge Fernández-Trillo
Jorge Fernández-Trillo
Luis PardoLuis Pardo
Luis Pardo
Voltage-gated channels open paths for ion permeation upon changes in membrane potential, but how voltage changes are coupled to gating is not entirely understood. Two modules can be recognized in voltage-gated potassium channels, one responsible for voltage sensing (transmembrane segments S1 to S4), the other for permeation (S5 and S6). It is generally assumed that the conversion of a conformational change in the voltage sensor into channel gating occurs through the intracellular S4–S5 linker that provides physical continuity between the two regions. Using the pathophysiologically relevant KCNH family, we show that truncated proteins interrupted at, or lacking the S4–S5 linker produce voltage-gated channels in a heterologous model that recapitulate both the voltage-sensing and permeation properties of the complete protein. These observations indicate that voltage sensing by the S4 segment is transduced to the channel gate in the absence of physical continuity between the modules.

1 January 2012 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
FBFrancisco Barros
Francisco Barros
PDPedro Domínguez
Pedro Domínguez
PPPilar de la Peña
Pilar de la Peña
The basic architecture of the voltage-dependent K+ channels (Kv channels) corresponds to a transmembrane protein core in which the permeation pore, the voltage-sensing components and the gating machinery (cytoplasmic facing gate and sensor–gate coupler) reside. Usually, large protein tails are attached to this core, hanging toward the inside of the cell. These cytoplasmic regions are essential for normal channel function and, due to their accessibility to the cytoplasmic environment, constitute obvious targets for cell-physiological control of channel behavior. Here we review the present knowledge about the molecular organization of these intracellular channel regions and their role in both setting and controlling Kv voltage-dependent gating properties. This includes the influence that they exert on Kv rapid/N-type inactivation and on activation/deactivation gating of Shaker-like and eag-type Kv channels. Some illustrative examples about the relevance of these cytoplasmic domains determining the possibilities for modulation of Kv channel gating by cellular components are also considered.

22 September 1998 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
FBFrancisco Barros
Francisco Barros
DGDavid Gómez‐Varela
David Gómez‐Varela
CVCristina G. Viloria
Cristina G. Viloria
TPTeresa Palomero
Teresa Palomero
TGTeresa Giraldez
Teresa Giraldez
PPPilar de la Peña
Pilar de la Peña

1 September 1987 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
BLB J Lee
B J Lee
PPP de la Peña
P de la Peña
JTJ A Tobian
J A Tobian
MZM Zasloff
M Zasloff
DHD Hatfield
D Hatfield
An opal suppressor phosphoserine tRNA gene is present in single copy in the genomes of higher vertebrates. We have shown that the product of this gene functions as a suppressor in an in vitro assay, and we have proposed that it may donate a modified amino acid directly to protein in response to specific UGA codons. In this report, we show through in vitro and in vivo studies that the human and Xenopus opal suppressor phosphoserine tRNAs are synthesized by a pathway that is, to the best of our knowledge, unlike that of any known eukaryotic tRNA. The primary transcript of this gene does not contain a 5''-leader sequence; and, therefore, transcription of this suppressor is initiated at the first nucleotide within the coding sequence. The 5''-terminal triphosphate, present on the primary transcript, remains intact through 3''-terminal maturation and through subsequent transport of the tRNA to the cytoplasm. The unique biosynthetic pathway of this opal suppressor may underlie its distinctive role in eukaryotic cells.

1 May 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PPPilar de la Peña
Pilar de la Peña
CACarlos Alonso-Ron
Carlos Alonso-Ron
AMAngeles Machín
Angeles Machín
JFJorge Fernández-Trillo
Jorge Fernández-Trillo
LCLuis Carretero
Luis Carretero
FBFrancisco Barros
Francisco Barros
Potassium channels encoded by the human ether-à-go-go-related gene (hERG) contribute to cardiac repolarization as a result of their characteristic gating properties. The hERG channel N terminus acts as a crucial determinant in gating. It is also known that the S4-S5 linker couples the voltage-sensing machinery to the channel gate. Moreover, this linker has been repeatedly proposed as an interaction site for the distal portion of the N terminus controlling channel gating, but direct evidence for such an interaction is still lacking. In this study, we used disulfide bond formation between pairs of engineered cysteines to demonstrate the close proximity between the beginning of the N terminus and the S4-S5 linker. Currents from channels with introduced cysteines were rapidly and strongly attenuated by an oxidizing agent, this effect being maximal for cysteine pairs located around amino acids 3 and 542 of the hERG sequence. The state-dependent modification of the double-mutant channels, but not the single-cysteine mutants, and the ability to readily reverse modification with the reducing agent dithiothreitol indicate that a disulfide bond is formed under oxidizing conditions, locking the channels in a non-conducting state. We conclude that physical interactions between the N-terminal-most segment of the N terminus and the S4-S5 linker constitute an essential component of the hERG gating machinery, thus providing a molecular basis for previous data and indicating an important contribution of these cytoplasmic domains in controlling its unusual gating and hence determining its physiological role in setting the electrical behavior of cardiac and other cell types.